Numb right leg; Unusual severe muscle pains off and on persisting; Mild twitch in right eye; Electrical shocks; nerve pain; Itching; Cardiac symptoms; Heart rate of up to 165, often in 130-150 range; Muscle weakness/dysfunction; Muscle weakness/dysfunction; Blurred vision; Swallowing dysfunction; Fatigue; Severe pelvic pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date Apr2021 (Lot number: ER8737) at the age of 44 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient didn't receive other vaccine in four weeks. The following information was reported: ELECTRIC SHOCK SENSATION (disability) with onset Apr2021, outcome "not recovered", described as "Electrical shocks"; NEURALGIA (disability) with onset Apr2021, outcome "not recovered", described as "nerve pain"; PRURITUS (disability) with onset Apr2021, outcome "not recovered", described as "Itching"; CARDIAC DISORDER (disability) with onset Apr2021, outcome "recovered" (2021), described as "Cardiac symptoms"; HEART RATE INCREASED (disability) with onset Apr2021, outcome "recovered" (2021), described as "Heart rate of up to 165, often in 130-150 range"; MUSCULAR WEAKNESS (disability), MUSCLE DISORDER (disability) all with onset Apr2021, outcome "not recovered" and all described as "Muscle weakness/dysfunction"; VISION BLURRED (disability) with onset Apr2021, outcome "not recovered", described as "Blurred vision"; DYSPHAGIA (disability) with onset Apr2021, outcome "not recovered", described as "Swallowing dysfunction"; FATIGUE (disability) with onset Apr2021, outcome "recovered" (2021), described as "Fatigue"; PELVIC PAIN (disability) with onset Apr2021, outcome "recovered" (2021), described as "Severe pelvic pain"; HYPOAESTHESIA (disability) with onset Jul2021, outcome "not recovered", described as "Numb right leg"; MYALGIA (disability) with onset Apr2021, outcome "not recovered", described as "Unusual severe muscle pains off and on persisting"; MUSCLE TWITCHING (disability) with onset Apr2021, outcome "not recovered", described as "Mild twitch in right eye". The events "electrical shocks", "nerve pain", "itching", "cardiac symptoms", "heart rate of up to 165, often in 130-150 range", "muscle weakness/dysfunction", "muscle weakness/dysfunction", "blurred vision", "swallowing dysfunction", "fatigue", "severe pelvic pain", "numb right leg", "unusual severe muscle pains off and on persisting" and "mild twitch in right eye" were evaluated at the physician office visit. Therapeutic measures were taken as a result of electric shock sensation, neuralgia, pruritus, cardiac disorder, heart rate increased, muscular weakness, muscle disorder, vision blurred, dysphagia, fatigue, pelvic pain, hypoaesthesia, myalgia, muscle twitching which included Valtrex prescription to see if helps ease symptoms. Clinical course: adverse event start time was 01:15 PM. Immediate reaction to vaccine starting 2 minutes after shot. Electrical shocks/nerve pain and widespread internal itching throughout body. Nerve pain has continued since then. It is intermittent, often sharp, in various random places on the body. Cardiac symptoms persisted for a month including resting heart rate of up to 165, often in 130-150 range; this resolved. Muscle weakness/dysfunction began soon after vaccine and continues to persist; initially strength was at 50% of normal; has improved slightly. Autonomic nervous system impacts include blurred vision and swallowing dysfunction, both persisting at 8 months. Fatigue onset for several weeks after vaccine but is resolved. Mild twitch in right eye is intermittent/persisting. Severe pelvic pain one month after vaccine, resolved. Numb right leg a few times in July 2021. Unusual severe muscle pains off and on persisting. The patient underwent the following laboratory tests and procedures: heart rate: (Apr2021) up to 165; (unspecified date) often in 130-150 range; sars-cov-2 test: (29Nov2021) negative.   Follow-up attempts are completed. No further information is expected.